Survivin is a novel inhibitor of apoptosis. It has been reported that survivin is expressed during fetal development and in cancer tissues, but its expression has not been reported in adult tissues. We investigated the expression of survivin in the endometria of women with regular menstrual cycles using reverse transcription-polymerase chain reaction (RT-PCR) and immunohistochemistry, and compared these findings with Bcl-2, an apoptosis inhibitor. Survivin mRNA was detected by RT-PCR in all samples (nine of nine) of endometrium during the secretory phase, but in only four out of seven samples from endometrium during the proliferative phase, and in none of the atrophic endometrium. Immunohistochemistry demonstrated a survivin protein expression that was strongest in the nuclei of glandular epithelial cells during the late secretory phase. In the proliferative phase, glandular epithelial cells were not stained for survivin. The cyclic changes of survivin and Bcl-2 showed an inverse relationship, with Bcl-2 expression being strongest in the proliferative phase and survivin expression being strongest in the secretory phase. The up-regulation of survivin expression may be due to the concurrent rise in progesterone concentrations during the normal menstrual cycle. Moreover, survivin could play an important role independent of Bcl-2 in physiological homeostasis in the normal endometrium.
Introduction
Menstruation has been recognized to be the result of ischaemic necrosis in the endometrium (Speroff and Vande Regulation of programmed cell death (apoptosis) preserves Wiele, 1971) . However, some authors (Hopwood and Levinson, normal homeostasis, and tissue and organ morphogenesis 1975) reported apoptotic bodies in the human endometrium (Vaux et al., 1994; Nagata, 1997) . Aberrations of this process by light and electron microscopy. Recently, it has been reported participate in human diseases and may contribute to carcinothat apoptosis appears in the human endometrium during the genesis by prolonging cell viability resulting in the menstrual cycle by DNA gel fragmentation and in-situ accumulation of transforming mutations (Thompson, 1995) . apoptosis analysis techniques (Kokawa et al., 1996) . Survivin is a new inhibitor of apoptosis protein (IAP) In addition, cyclic Bcl-2 expression in the human endometexpressed during development and in human malignancy. The rium has been demonstrated by several investigators (Gompel survivin gene was recently identified by hybridization screening et al, 1994; Otsuki et al., 1994; Tabibzadeh et al., 1995 ; Koh of human genomic libraries with the cDNA from a factor Xa et al., 1995; Jones et al., 1998) . Endometrial glandular cells receptor, effector cell protease receptor-1 (EPR-1) (Altieri, express Bcl-2 during the proliferative phase, but not during 1995; Ambrosini et al., 1997) .
the late secretory phase. The disappearance of Bcl-2 expression Survivin can bind specifically to the terminal effector cell during the late secretory phase is consistent with the appearance death proteases, caspase-3 and -7 in vitro, and inhibit caspase of apoptotic cells during this same phase. Bcl-2 expression in activity and apoptosis in cells exposed to diverse apoptotic glandular cells may also be regulated by steroid hormones stimuli (Tamm et al., 1998) . Survivin has been shown to be (Gompel et al., 1994; Otsuki et al., 1994; Koh et al., 1995; expressed in 60 cancer cell lines, including breast, colon, Tabibzadeh et al., 1995). brain, leukaemia/lymphoma, lung, melanoma, ovarian, prostate To our knowledge, there has been no investigation of the and renal cancer (Tamm et al., 1998) .
expression of survivin in normal human endometrium during Survivin expression has been shown to be present during the menstrual cycle. Thus, the role of survivin and its mechanfetal development. In contrast, survivin transcripts were undeism during menstruation in normal human endometrium is tectable in terminally differentiated adult tissues, including unknown. In this study, we examined the expression of survivin peripheral blood leukocytes, lymph node, spleen, pancreas, and compared it with Bcl-2 in the normal human endometrium kidney, skeletal muscle, liver, lung, brain, and heart (Ambrosini during the menstrual cycle by immunohistochemistry and et al., 1997), reminiscent of the expression of another apoptosis inhibitor, Bcl-2, in these adult organs (LeBurn et al., 1993) .
reverse transcription-polymerase chain reaction (RT-PCR). Positivity (P) was scored as follows: 0 ϭ Ͻ5%; 1 ϭ 5-25%; 2 ϭ 25-50%; 3 ϭ 50-75%; and 4 ϭ Ͼ75%.
The immunostaining intensity (I) was scored as follows: 1ϩ (weak); 2ϩ (moderate), or 3ϩ (intense).
Materials and methods
at least five areas at ϫ400 magnification and assigned to one of the following categories: 0 ϭ Ͻ5%; 1 ϭ 5-25%; 2 ϭ 25-50%; 3 ϭ 50-Immunohistochemistry 75%; and 4 ϭ Ͼ75%. The immunostaining intensity of survivin and Tissue samples of endometria for immunohistochemistry were Bcl-2 were scored as 1ϩ (weak), 2ϩ (moderate) or 3ϩ (intense). obtained from 20 women (age, mean Ϯ SD, 44.8 Ϯ 3.09, range 40-
The relative intensity of survivin staining defined as 3ϩ was identical 50 years; four early proliferative, three mid-proliferative, three late to the intensity of Bcl-2 staining in stromal lymphocytes. The proliferative, four early secretory, four mid-secretory, two late secretpercentage of positive glandular epithelial cells and the staining ory phase) with regular menstruation (Table I) . They underwent intensity were multiplied to produce a weighted score for each case. hysterectomy with the diagnosis of cervical intra-epithelial neoplasia Immunostaining findings of stromal cells, glandular epithelial cells at Tohoku University Hospital, Sendai, Japan, after informed consent obtained from basal layer, and superficial epithelial cells in the was obtained. They had received no hormone treatment prior to endometrium were described without scoring. surgery. Formalin-fixed and paraffin-embedded samples were prepared Statistical analyses were carried out using the Kruskal-Wallis test, for histological diagnosis and immunohistochemical analysis. There Scheffé's F test and Pearson' s correlation coefficient test. P Ͻ 0.05 were no pathological findings related to the endometrium during postwas considered to be statistically significant. operative pathological examination of all samples used in the present study. Endometrial dating was performed according to Noyes' criteria RT-PCR (Noyes et al., 1950) .
A total of 19 normal endometrial samples were used in this study, Immunohistochemistry was performed using the LSAB 2 Kit (Dako including 16 samples from women with regular menstrual cycles Japan, Kyoto, Japan) and an antigen retrieval method. The primary (age, mean Ϯ SD, 44.6 Ϯ 5.21, range 33-51 years; proliferative antibodies were polyclonal rabbit anti-human survivin (Surv 11; Alfa phase, seven cases; secretory phase, nine cases) and three samples Diagnostic International, San Antonio, TX, USA) and monoclonal from post-menopausal women (age, mean Ϯ SD, 52.7 Ϯ 6.35, range mouse anti-human Bcl-2 (Dako Japan). After deparaffinization, sec-49-60 years). These tissues were obtained after hysterectomy in tions were treated with methanol/hydrogen peroxide for 5 min to patients diagnosed with cervical intraepithelial neoplasia, following block endogenous peroxidase. To retrieve masked antigens, the slides informed consent. They had normal regular menstrual cycles and had were immersed in citrate buffer (pH 6.0), and heated in an autoclave received no hormone treatment prior to surgery. The endometrial for 5 min at 120°C. The slides were incubated for 60 min with the tissues collected were assessed for histopathological diagnosis accordprimary antibody, followed by a 30 min incubation with the biotinyling to previously described criteria (Noyes et al., 1950) , and the ated secondary antibody, and then with peroxidase-labelled streptaviremaining portions of the samples were frozen at -80°C until assay. din for 30 min. Negative control slides in the absence of primary antibody were included for each staining. Finally, 3,3Ј-diamino-RNA extraction and first strand cDNA synthesis using benzidine was used to develop the colour, and haematoxylin was oligo(dT) used for counterstaining.
For the semi-quantitative evaluation of survivin and Bcl-2 expresTotal RNA was isolated from frozen human endometrial tissue using a commercially available extraction method (Isogen, Nippon Gene sion, we used a scoring method modified by Sinicrope and Lu (Lu et al., 1998) . The mean percentage of positive glandular epithelial Inc, Tokyo, Japan). First-strand cDNA was synthesized from 3-4 µg of total RNA using an Oligo(dT)12-18 primer and the Superscript™ cells in the functional layer of the endometrium was determined in Figure 1 . Expression of survivin in endometrial glandular epithelial cells throughout the menstrual cycle. P1 ϭ early proliferative phase; P2 ϭ mid-proliferative phase; P3 ϭ late proliferative phase; Figure 2 . Expression of Bcl-2 in endometrial glandular epithelial S1 ϭ early secretory phase; S2 ϭ mid-secretory phase; S3 ϭ late cells throughout the menstrual cycle. P1 ϭ early proliferative secretory phase. Staining score was calculated as described in the phase; P2 ϭ mid-proliferative phase; P3 ϭ late proliferative phase; text. Error bar Ϯ SD. Kruskal-Wallis test, P ϭ 0.0096. P values of S1 ϭ early secretory phase; S2 ϭ mid-secretory phase; S3 ϭ late Scheffe's F-test are indicated above. secretory phase. Staining score was calculated as described in the text. Error bar Ϯ SD. Kruskal-Wallis test, P ϭ 0.0047. P values of Preamplification System (Superscript™ II RT; 200 IU; Gibco BRL, Scheffe's F-test are indicated above. Grand Island, NY, USA). Control RNA is included in this kit to verify system performance. One µl (50 ng) of control RNA was used as a template for first strand cDNA synthesis. Immunostaining for Bcl-2 disappeared from glandular epithelial cells as soon as secretory phase characteristics appeared
Results
( Figure 3F ). In the premenstrual phase, the basal layer of the Results of immunohistochemistry are summarized in Table I glandular cells was positive for Bcl-2 immunoreactive protein, and Figures 1 and 2. as was found in the proliferative phase. Immunopositive stromal cells increased during the secretory phase, and peaked Immunohistochemistry for survivin in the late secretory phase. Of the predecidualized stromal Proliferative phase cells, some stromal granular lymphocytes were positive for BclThe glandular epithelium and stroma were negative or very 2, but predecidual cells were negative. The surface epithelium weakly positive for survivin immunostaining ( Figure 3A) . The stained heterogenously and weakly for Bcl-2 protein. surface epithelium ( Figure 3B ) and basal layer cells stained weakly and heterogenously in proliferative phase samples.
Relationship between survivin and Bcl-2 Staining was localized to the cytoplasm.
Immunohistochemistry data on survivin and Bcl-2 staining in the normal endometrium during the menstrual cycle are shown Secretory phase Immunolocalization of survivin was confined to the glandular in Figures 1 and 2 . The cyclic changes of survivin and Bcl-2 protein expression demonstrated an inverse relationship epithelial cells. The staining pattern was different between the between the proliferative phase and the secretory phase ( Figure  observed to be down-regulated and/or undetectable in many 4). In the secretory phase, immunostaining was positive for normal adult tissues (Ambrosini et al., 1997) , but present in survivin but negative for Bcl-2, while in the proliferative the thymus and placenta. The expression of survivin has not, phase, it was negative for survivin but positive for Bcl-2.
however, been investigated in normal human endometrium. This is the first study investigating survivin expression in RT-PCR of survivin the normal endometrium as it relates to hormonal fluctuations In the normal endometrium, survivin mRNA expression was during the menstrual cycle. Prior to obtaining our results, detected using RT-PCR in four out of seven endometrial we expected that survivin might be expressed during the samples obtained during the proliferative phase, in all of nine proliferative phase, as was observed for Bcl-2 expression in samples from secretory phase endometria, and in none out of previous reports (Gompel et al, 1994; Otsuki 1994 ; Saitoh three inactive endometria ( Figure 5) . et al, 1999) . In fact, the results from our experiments by immunohistochemistry and RT-PCR clearly show that survivin Discussion is expressed during the secretory phase, and is rare or absent in the proliferative phase. It has been reported that survivin is expressed during embryonic and fetal development. However, its expression has been Expression of Bcl-2 has been demonstrated in normal endometrium during the menstrual cycle, being associated with the role of survivin in the mechanism of apoptosis in normally oestrogen and progesterone status. Our finding that Bcl-2 cycling endometrium. immunohistochemical staining predominated in glandular cells,
We pointed out in the present study that the immunostaining peaking during the proliferative phase and disappearing at the pattern for survivin is different between glandular epithelial onset of the secretory phase, coincides with previous studies cells during the secretory phase and superficial cells during (Gompel et al, 1994; Otsuki et al., 1994; Koh et al., 1995) . the proliferative phase. Nuclear staining was observed in Among the regulators of programmed cell death (apoptosis), glandular epithelial cells of the functional layer during the IAP have recently attracted considerable attention for their secretory phase. On the other hand, immunostaining was ability to suppress an evolutionarily conserved step in apoptosis cytoplasic in the proliferative phase, similar to that of the (Clem and Duckett, 1997) , potentially involving direct caspase basal layer during the secretory phase. Furthermore, in previous inhibition (Deveraux et al., 1997) . It has been reported that reports concerning cancer tissues, immunohistochemical stainsurvivin binds specifically to terminal effector cell death ing was observed in the cytoplasm and not in nuclei (Ambrosini proteases, caspase-3 and -7 in vitro and inhibits caspase activity et al., 1997; Lu et al., 1998) . It is probable that the difference of and cell death in cells exposed to diverse apoptotic stimuli immunolocalization for survivin is due to survivin-microtubule (Tamm et al., 1998) . Moreover, survivin is expressed in the interactions. Since there is insufficient data to state a clear G 2 /M phase of the cell cycle in a cell-regulated manner. At relationship between the staining patterns and any G 2 /M the beginning of mitosis, survivin associates with microtubules checkpoints, further study is necessary. of the mitotic spindle in a specific and saturable reaction that
In addition, we found that the expression of caspase-3 was is regulated by microtubule dynamics. Disruption of survivindemonstrated immunohistochemically in endometrial glandular microtubule interactions results in the loss of survivin's cells during the secretory phase, and not in the proliferative anti-apoptosis function and increased caspase-3 activity, a phase (R.Konno, unpublished data). It is likely that survivin mechanism involved in cell death, during mitosis. These results may be expressed antagonistically to caspase-3 expression in suggest that survivin may counteract a default induction of order to keep the balance between inhibition and induction of apoptosis in the G 2 /M phase of the cell cycle (Fengzhi et al., apoptosis in the secretory phase. It is reasonable to suggest 1998). The above information is seen to be of value considering that the up-regulation of survivin expression by progesterone could play a role in the physiological homeostasis in normal endometrium.
In the present study, we found that immunohistochemical staining of survivin was restricted to endometrial glandular epithelium and was negative in endometrial stromal cells, while stromal cells were positive for Bcl-2. Previous studies (Koh et al., 1995; Jones et al., 1998; Konno et al., 1999) have demonstrated that most of the endometrial stromal granulocytes during the secretory phase were CD56-positive natural killer cells, containing perforin and granzyme B, which are cytotoxic granules inducing apoptosis (Konno et al., 1999) , and revealed that endometrial stromal granulocytes were also expressing caspase-3 (R.Konno, unpublished data). Moreover, it has been suggested that endometrial stromal granulocytes expressing Bcl-2 and Ki67 simultaneously do not undergo apoptosis (Jones et al., 1998) . We speculate that endometrial stromal cells mechanism, but not using survivin. In summary, survivin expression was demonstrated in the endometrium during the secretory phase in the human adult. It is suggested that survivin may play a role in the mechanism of endometrial menstruation independent of Bcl-2 expression.
